Navigation Links
Researchers Identify Genes Tied to Breast Cancer that Spreads to the Brain
Date:9/20/2013

Chicago (PRWEB) September 20, 2013

Researchers have identified the epigenetic markers that determine whether breast cancer will spread to the brain, which could lead to earlier diagnoses and more effective treatment, suggests a study being presented today at ASCP 2013 Chicago, the annual meeting of the American Society for Clinical Pathology.

Breast cancer is the leading cause of cancer and the second most common cause of cancer death among U.S. women, according to the Centers for Disease Control and Prevention (CDC). Some breast cancers are more likely to spread beyond the breast (metastasize), including to the brain. Currently, doctors don’t have a clear picture at diagnosis regarding which breast cancers are likely to metastasize to the brain and which are not. Encouragingly, researchers have recently identified molecular markers called micro ribonucleic acids (RNAs) as potentially playing a role.

“Survival rates are low once breast cancer metastasizes to the brain,” said Seema Sethi, MD, a resident at Wayne State University and Detroit Medical Center, and lead author of the study. “This research will help us develop targeted therapies so we can more aggressively treat patients with this form of breast cancer.”

Researchers extracted micro RNA from the tumors of 90 women with breast cancer, including 45 whose cancer had spread to the brain (metastasized) and 45 whose cancer had not. After analyzing the data, researchers found that several micro RNAs were significantly altered in patients whose breast cancer had spread to the brain. They also identified several target genes involved in the process.

Researchers believe these micro RNAs and their target genes could help identify which breast cancers eventually will metastasize to the brain when the cancer is first diagnosed and determine the course of therapy, including how aggressive treatment should be. This newer approach, called personalized medicine, means targeted therapies and specific treatment options would be available depending on each patient’s medical history and epigenetic markers.

# # # # #

ASCP 2013 Chicago will be held at the Hyatt Regency Chicago, 151 E. Upper Wacker Dr., in Chicago. For more information about the meeting, visit http://www.ascp.org/ascp2013.

About the American Society for Clinical Pathology
Founded in 1922 in Chicago, ASCP is a medical professional society with more than 100,000 member board-certified anatomic and clinical pathologists, pathology residents and fellows, laboratory professionals, and students. ASCP provides excellence in education, certification, and advocacy on behalf of patients, pathologists, and laboratory professionals. For more information, visit http://www.ascp.org.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11145625.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UC Davis Researchers Find How Viral Infection Disrupts Neural Development in Offspring, Increasing Risk of Autism
2. IOActive Ramps Up Recruitment for Top Security Researchers and Consultants in South America
3. UI researchers: Bracing is effective in adolescents with idiopathic scoliosis
4. CWRU researchers find what stresses parents with a chronically ill child
5. Yale researchers see decline in hospitalizations for serious heart infection
6. Researchers identify novel biomarker for diabetes risk
7. Tufts researchers identify how Yersinia spreads within infected organs
8. Approved cancer drug potentially could help treat diabetes, Stanford researchers find
9. Mount Sinai Researchers Show Stem Cells Are Wired for Cooperation, Down to the DNA
10. Virginia Tech Carilion researchers find surprising relationships in brain signaling
11. Researchers to identify genetic biomarkers for aggressive breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology: